Insider Transactions in Q4 2022 at Volitionrx LTD (VNRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+8.87%
|
$10,000
$2.27 P/Share
|
|
Dec 19
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+11.72%
|
$50,000
$2.3 P/Share
|
|
Dec 16
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
7,339
+4.3%
|
$7,339
$1.96 P/Share
|
|
Dec 16
2022
|
Martin Charles Faulkes Executive Director |
BUY
Open market or private purchase
|
Direct |
55,000
+3.25%
|
$110,000
$2.1 P/Share
|
|
Dec 12
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
4,350
+8.58%
|
$8,700
$2.09 P/Share
|
|
Dec 08
2022
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Open market or private purchase
|
Direct |
4,800
+8.53%
|
$9,600
$2.07 P/Share
|
|
Nov 28
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+10.64%
|
$10,000
$2.21 P/Share
|
|
Nov 10
2022
|
Guy Archibald Innes |
BUY
Bona fide gift
|
Indirect |
49,726
+11.46%
|
-
|
|
Nov 10
2022
|
Guy Archibald Innes |
SELL
Bona fide gift
|
Indirect |
49,726
-100.0%
|
-
|
|
Nov 10
2022
|
Guy Archibald Innes |
BUY
Acquisition or disposition by will or laws
|
Indirect |
34,288
+9.3%
|
-
|
|
Nov 01
2022
|
Nicholas Plummer GC, Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
9,406
-16.77%
|
$9,406
$1.97 P/Share
|
|
Oct 13
2022
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+9.57%
|
-
|
|
Oct 13
2022
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,825
+0.43%
|
-
|
|
Oct 13
2022
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
8,575
+19.23%
|
-
|
|
Oct 13
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,825
+4.19%
|
-
|
|
Oct 13
2022
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+0.17%
|
-
|
|
Oct 13
2022
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,950
+8.1%
|
-
|
|
Oct 13
2022
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,050
+9.88%
|
-
|
|
Oct 13
2022
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
9,100
+13.96%
|
-
|
|
Oct 13
2022
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+26.42%
|
-
|
|
Oct 13
2022
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+10.53%
|
-
|
|
Oct 13
2022
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,775
+11.09%
|
-
|
|
Oct 13
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
11,200
+7.12%
|
-
|
|
Oct 13
2022
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,825
+20.96%
|
-
|
|
Oct 13
2022
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,625
+6.42%
|
-
|
|
Oct 13
2022
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,575
+1.09%
|
-
|
|
Oct 13
2022
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+1.56%
|
-
|
|
Oct 13
2022
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+5.45%
|
-
|
|
Oct 04
2022
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+12.54%
|
-
|
|
Oct 04
2022
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+42.74%
|
-
|
|
Oct 04
2022
|
Michel Gaetan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,883
-16.84%
|
$6,883
$1.46 P/Share
|
|
Oct 04
2022
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+43.34%
|
-
|
|
Oct 04
2022
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.08%
|
-
|